Haijiao Lu
Huaihai West Road No.241
Huaihai, 200030, China
Huaihai, 200030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Real-world outcomes of trastuzumab deruxtecan as second- or further-line treatment in patients with HER2-mutant metastatic non-small cell lung cancer: a retrospective study.
Journal: Translational lung cancer research
Published: August 06, 2025
Cadonilimab plus chemotherapy as first-line treatment in PD-L1-negative advanced non-small cell lung cancer: a phase II clinical trial.
Journal: Nature communications
Published: July 03, 2025
Cis-Regulation of an m6A Eraser by an Insertion Variant Associated with Survival of Patients With Non-Small Cell Lung Carcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 10, 2024
YY1 downregulation underlies therapeutic response to molecular targeted agents.
Journal: Cell death & disease
Published: June 17, 2024
Neoadjuvant immunology therapy in patients with non-small cell lung cancer and chronic obstructive pulmonary disease.
Journal: Journal of thoracic disease
Published: May 17, 2024
Anti-angiogenic therapy or immunotherapy? A real-world study of patients with advanced non-small cell lung cancer with EGFR/HER2 exon 20 insertion mutations.
Journal: Frontiers in oncology
Published: December 19, 2023
Immunotherapy combined with chemotherapy for patients with pulmonary large cell neuroendocrine carcinoma.
Journal: Chinese medical journal
Published: October 18, 2023
Efficacy of alectinib in lung adenocarcinoma patients with different anaplastic lymphoma kinase (ALK) rearrangements and co-existing alterations-a retrospective cohort study.
Journal: Translational lung cancer research
Published: October 13, 2023
Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma.
Journal: BMJ open respiratory research
Published: June 08, 2023
Last Updated: 09/26/2026